REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma | MicrobiomeTrials
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-07-20Est. Completion: 2030-10-27
Enrollment target: 265 participants
Locations
City of Hope Phoenix, Goodyear, Arizona, United States
City of Hope, Duarte, California, United States
H. Lee Moffitt Cancer Center, Tampa, Florida, United States
City of Hope Chicago, City of Hope Cancer Center Chicago, Zion, Illinois, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States